Skip to content

Clinical trials

Uterine Cervical Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Country / region: China Clear all

420 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20083
20091
20106
20119
20129
20136
201515
201610
201715
201816
201930
202032
202150
202253
202344
202458
202537
202622

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status166
Recruiting103
Completed71
Not yet recruiting30
Active, not recruiting29
Terminated10
Withdrawn5
Enrolling by invitation4
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lei Li22
Peking Union Medical College Hospital19
Sun Yat-sen University18
Huazhong University of Science and Technology16
Chongqing University Cancer Hospital10
Xiamen University10
Fujian Cancer Hospital9
Obstetrics & Gynecology Hospital of Fudan University9
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University9
Shanghai Bovax Biotechnology Co., Ltd.8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms420
Ovarian Neoplasms48
Endometrial Neoplasms42
Uterine Cervical Dysplasia30
Papillomavirus Infections22
Breast Neoplasms19
Carcinoma, Non-Small-Cell Lung19
Condylomata Acuminata19
Vulvar Neoplasms17
Lung Neoplasms16

Trials

Showing 26 to 50 of 420. Each trial links to its page on Pharma Observatory.

320 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.